Incidence Rates of Diseases and Conditions Commonly Seen in Primary Care, 2017–2020
| Incidence Rate (95% CI), Cases per 1,000 Persons | 2020 vs 2019, IRR (95% CI) | 2020 vs 2017–2019, IRR (95% CI) | ||||
|---|---|---|---|---|---|---|
| Disease/condition | 2017 | 2018 | 2019 | 2020 | ||
| Cardiovascular risk factors and diseases | ||||||
| Hypercholesterolemia | 17.11 | 15.88 | 17.69 | 10.78 | 0.61 | 0.64 |
| (15.88-18.42) | (14.72-17.11) | (16.47-18.97) | (9.86-11.77) | (0.54-0.68) | (0.57-0.72) | |
| Hypertension | 14.06 | 14.20 | 13.35 | 8.26 | 0.62 | 0.60 |
| (12.96-15.22) | (13.11-15.34) | (12.31-14.46) | (7.46-9.12) | (0.54-0.70) | (0.52-0.68) | |
| Type 2 diabetes | 6.10 | 6.36 | 6.71 | 3.93 | 0.59 | 0.61 |
| (5.46-6.81) | (5.71-7.06) | (6.05-7.42) | (3.44-4.47) | (0.50-0.69) | (0.52-0.73) | |
| Chronic kidney disease | 6.77 | 5.33 | 7.03 | 3.64 | 0.52 | 0.57 |
| (6.10-7.48) | (4.75-5.96) | (6.37-7.75) | (3.18-4.15) | (0.44-0.61) | (0.48-0.68) | |
| Heart failure | 2.15 | 2.97 | 3.31 | 2.54 | 0.77 | 0.90 |
| (1.79-2.57) | (2.54-3.44) | (2.87-3.81) | (2.16-2.96) | (0.62-0.95) | (0.72-1.12) | |
| Stroke | 1.86 | 2.22 | 1.74 | 1.86 | 1.07 | 0.96 |
| (1.52-2.25) | (1.86-2.64) | (1.42-2.11) | (1.54-2.23) | (0.81-1.40) | (0.73-1.25) | |
| Ischemic cardiomyopathy | 3.24 | 2.23 | 2.24 | 1.32 | 0.59 | 0.52 |
| (2.79-3.75) | (1.86-2.64) | (1.87-2.65) | (1.05-1.64) | (0.44-0.78) | (0.39-0.68) | |
| Acute myocardial infarction | 0.99 | 0.96 | 0.87 | 1.14 | 1.31 | 1.22 |
| (0.75-1.29) | (0.72-1.24) | (0.65-1.14) | (0.89-1.44) | (0.91-1.91) | (0.84-1.76) | |
| Chronic noncardiovascular diseases | ||||||
| Dementia | 6.25 | 7.40 | 9.64 | 6.77 | 0.70 | 0.87 |
| (5.60-6.95) | (6.71-8.14) | (8.85-10.47) | (6.13-7.45) | (0.62-0.80) | (0.76-1.00) | |
| Asthma | 5.34 | 6.86 | 5.68 | 5.07 | 0.89 | 0.85 |
| (4.74-5.99) | (6.19-7.59) | (5.07-6.33) | (4.51-5.68) | (0.76-1.05) | (0.72-1.00) | |
| Benign prostatic | 9.00 | 9.23 | 8.25 | 5.47 | 0.66 | 0.62 |
| hypertrophy | (8.23-9.83) | (8.46-10.06) | (7.52-9.03) | (4.89-6.10) | (0.57-0.77) | (0.54-0.72) |
| Hypothyroidism/thyroiditis | 7.39 | 7.32 | 7.92 | 4.07 | 0.51 | 0.54 |
| (6.67-8.16) | (6.62-8.08) | (7.20-8.70) | (3.57-4.63) | (0.44-0.60) | (0.46-0.63) | |
| Osteoporosis | 5.83 | 4.92 | 5.76 | 3.31 | 0.57 | 0.60 |
| (5.20-6.52) | (4.35-5.54) | (5.15-6.43) | (2.86-3.81) | (0.48-0.69) | (0.50-0.72) | |
| COPD | 2.73 | 2.75 | 3.22 | 1.46 | 0.45 | 0.50 |
| (2.31-3.20) | (2.33-3.21) | (2.78-3.72) | (1.18-1.80) | (0.35-0.59) | (0.39-0.65) | |
| Mental health disorders and health problems | ||||||
| Anxiety | 24.03 | 26.37 | 32.37 | 31.94 | 0.99 | 1.16 |
| (22.65-25.46) | (24.95-27.84) | (30.81-33.98) | (30.4-33.53) | (0.92-1.06) | (1.07-1.24) | |
| Depression | 6.90 | 7.05 | 7.60 | 6.21 | 0.82 | 0.86 |
| (6.20-7.66) | (6.35-7.80) | (6.88-8.37) | (5.58-6.90) | (0.71-0.95) | (0.74-1.00) | |
| Alcohol use disorder | 1.32 | 1.54 | 1.78 | 0.84 | 0.47 | 0.54 |
| (1.04-1.66) | (1.23-1.89) | (1.45-2.15) | (0.62-1.10) | (0.33-0.66) | (0.38-0.77) | |
| Violence against womena | 1.05 | 0.78 | 0.89 | 0.91 | 1.03 | 1.01 |
| (0.73-1.46) | (0.52-1.14) | (0.60-1.26) | (0.63-1.28) | (0.61-1.74) | (0.60-1.70) | |
| Cancer | ||||||
| Screening-detected cancers/tumors | 8.76 | 9.89 | 8.01 | 5.82 | 0.73 | 0.65 |
| (7.99-9.58) | (9.08-10.75) | (7.29-8.78) | (5.22-6.47) | (0.63-0.84) | (0.57-0.75) | |
| Breast cancera | 3.61 | 2.68 | 3.11 | 2.44 | 0.78 | 0.78 |
| (2.98-4.32) | (2.15-3.29) | (2.54-3.76) | (1.95-3.01) | (0.58-1.05) | (0.58-1.05) | |
| Colon cancer | 0.65 | 0.96 | 0.65 | 0.68 | 1.05 | 0.91 |
| (0.46-0.90) | (0.72-1.24) | (0.47-0.89) | (0.50-0.92) | (0.66-1.66) | (0.58-1.41) | |
| Benign colon polyps/tumors | 5.76 | 7.06 | 5.27 | 3.51 | 0.67 | 0.58 |
| (5.14-6.42) | (6.39-7.78) | (4.70-5.89) | (3.05-4.01) | (0.56-0.80) | (0.49-0.69) | |
| Cancers normally symptom detected | 4.46 | 4.04 | 4.81 | 3.63 | 0.75 | 0.82 |
| (3.92-5.05) | (3.54-4.60) | (4.27-5.41) | (3.17-4.14) | (0.63-0.90) | (0.68-0.98) | |
| Prostate cancer | 3.25 | 3.12 | 2.88 | 2.26 | 0.78 | 0.73 |
| (2.56-4.08) | (2.45-3.91) | (2.25-3.64) | (1.72-2.91) | (0.54-1.12) | (0.51-1.05) | |
| Lung cancer | 0.55 | 0.43 | 0.60 | 0.74 | 1.24 | 1.42 |
| (0.37-0.77) | (0.28-0.63) | (0.42-0.83) | (0.55-0.99) | (0.79-1.97) | (0.88-2.32) | |
| Bladder cancer | 0.69 | 0.75 | 0.87 | 0.67 | 0.77 | 0.87 |
| (0.49-0.94) | (0.55-1.01) | (0.65-1.14) | (0.48-0.90) | (0.50-1.17) | (0.55-1.35) | |
| Liver cancer | 0.09 | 0.20 | 0.08 | 0.11 | 1.33 | 0.88 |
| (0.03-0.20) | (0.11-0.36) | (0.03-0.19) | (0.04-0.23) | (0.36-5.31) | (0.27-2.89) | |
| Thyroid cancer | 0.33 | 0.12 | 0.32 | 0.09 | 0.30 | 0.37 |
| (0.20-0.52) | (0.05-0.25) | (0.19-0.49) | (0.03-0.21) | (0.10-0.78) | (0.12-1.01) | |
| Melanoma | 0.69 | 0.68 | 0.80 | 0.40 | 0.49 | 0.55 |
| (0.49-0.94) | (0.49-0.93) | (0.59-1.06) | (0.26-0.59) | (0.29-0.82) | (0.32-0.92) | |
| Stomach cancer | 0.12 | 0.07 | 0.13 | 0.11 | 0.83 | 1.02 |
| (0.05-0.25) | (0.02-0.17) | (0.06-0.26) | (0.04-0.23) | (0.26-2.62) | (0.30-3.59) | |
| Kidney cancer | 0.46 | 0.32 | 0.57 | 0.27 | 0.47 | 0.60 |
| (0.30-0.67) | (0.19-0.50) | (0.39-0.79) | (0.16-0.43) | (0.25-0.87) | (0.31-1.14) | |
| Lymphoma/leukemia | 0.11 | 0.10 | 0.13 | 0.17 | 1.30 | 1.53 |
| (0.04-0.23) | (0.04-0.22) | (0.06-0.26) | (0.09-0.31) | (0.48-3.74) | (0.53-4.76) | |
COPD = chronic obstructive pulmonary disease; IRR = incidence rate ratio.
Note: Bold denotes statistically significant (P < .05) incidence rate ratios.
↵aIn women.